Scripps MD Anderson Cancer Center

https://www.Scripps.org/HemOncCME

 

Scripps' 2019 ASCO Update on FOLFOXIRI plus Bevacizumab in Unresectable mCRC - Is the Upfront Exposure Beneficial?

422 views
September 17, 2019
0 Comments
Login to view comments. Click here to Login
2019 Oncology Update Videos